Associations of MDR1 , TBXA2R , PLA2G7 , and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy
Ling-ling Peng,Yuan-qi Zhao,Zi-yi Zhou,Jing Jin,Min Zhao,Xin-meng Chen,Ling-yan Chen,Ye-feng Cai,Jia-li Li,Min Huang
DOI: https://doi.org/10.1038/aps.2016.90
IF: 7.169
2016-01-01
Acta Pharmacologica Sinica
Abstract:Aim: Aspirin resistance has an incidence of 5%–65% in patients with ischemic stroke, who receive the standard dose of aspirin, but the platelet function is inadequately inhibited, thereby leading to thrombotic events. Numerous evidence shows that thromboxane A 2 receptor (TXA 2 receptor, encoded by TBXA2R ), lipoprotein-associated phospholipase A 2 (Lp-PLA 2 , encoded by PLA2G7 ) and platelet endothelial aggregation receptor-1 ( PEAR1 , encoded by PEAR1 ) are crucial in regulating platelet activation, and P-glycoprotein (P-gp, encoded by MDR1 ) influences the absorption of aspirin in the intestine. In this study we examined the correlation between MDR1 , TBXA2R , PLA2G7 , PEAR1 genetic polymorphisms and platelet activity in Chinese ischemic stroke patients receiving aspirin therapy. Methods: A total of 283 ischemic stroke patients receiving 100 mg aspirin for 7 d were genotyped for polymorphisms in MDR1 C3435T, TBXA2R (rs1131882), PLA2G7 (rs1051931, rs7756935), and PEAR1 (rs12566888, rs12041331). The platelet aggregation response was measured using an automatic platelet aggregation analyzer and a commercially available TXB 2 ELISA kit. Results: Thirty-three patients (11.66%) were insensitive to aspirin treatment. MDR1 3435TT genotype carriers, whose arachidonic acid (AA) or adenosine diphosphate (ADP)-induced platelet aggregation was lower than that of CC+CT genotype carriers, were less likely to suffer from aspirin resistance (odds ratio=0.421, 95% CI: 0.233–0.759). The TBXA2R rs1131882 CC genotype, which was found more frequently in the aspirin-insensitive group (81.8% vs 62.4%) than in the sensitive group, was identified as a risk factor for aspirin resistance (odds ratio=2.712, 95% CI: 1.080–6.810) with a higher level of AA-induced platelet aggregation. Due to the combined effects of PLA2G7 rs1051931 and rs7756935, carriers of the AA-CC haplotype had a higher level of ADP-induced platelet aggregation, and were at considerably higher risk of aspirin resistance than noncarriers (odds ratio=8.233, 95% CI: 1.590–42.638). Conclusion: A considerable portion (11.66%) of Chinese ischemic stroke patients are insensitive to aspirin treatment, which may be correlated with the MDR1 C3435T, TBXA2R (rs1131882), and PLA2G7 (rs1051931–rs7756935) polymorphisms.